Results 11 to 20 of about 1,107 (189)

Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma

open access: yesEBioMedicine, 2017
Aurora B kinase has emerged as a key regulator of mitosis and deregulation of Aurora B activity is closely related to the development and progression of human cancers.
Xinfang Yu   +5 more
doaj   +2 more sources

Prediction of new C-terminal Hsp90 inhibitors based on deguelin scaffold: homology modeling, virtual screening, QM/MM docking, MM/GBSA, and molecular dynamics simulations [PDF]

open access: yesResearch in Pharmaceutical Sciences
Background and purpose: The N-terminal Hsp90 inhibitors are promising targets for cancer treatment; however, inducing the heat shock response is one of the most significant limitations.
Maryam Abbasi   +2 more
doaj   +2 more sources

Deguelin inhibits perineural invasion in esophageal squamous cell carcinoma via targeting BDNF/TrkB axis [PDF]

open access: yesCancer Biology & Therapy
Background Perineural invasion (PNI) represents a uniquely distinctive pathway for tumor metastasis, but its underlying molecular mechanisms and therapy remain unclear.Methods Bioinformatics analysis and transcriptomic sequencing were first employed to ...
Qiying Wei   +7 more
doaj   +2 more sources

Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway

open access: yesCancer Management and Research, 2018
Liubo Chen,1,2,* Kai Jiang,1,2,* Haiyan Chen,1,3,* Yang Tang,1,2 Xinyi Zhou,1,2 Yinuo Tan,1,4 Ying Yuan,1,4 Qian Xiao,1,2 Kefeng Ding1,2 1Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key ...
Chen L   +8 more
doaj   +1 more source

Novel insights into immunopathogenesis and crucial biomarkers between primary open-angle glaucoma and systemic lupus erythematosus. [PDF]

open access: yesIMetaOmics
This study revealed a novel correlation between systemic lupus erythematosus (SLE) and primary open‐angle glaucoma (POAG) through comprehensive bioinformatics analysis and experimentation, identifying biomarkers and immunopathogenesis for future research and treatment of SLE‐related POAG.
Liu Y   +5 more
europepmc   +2 more sources

Deguelin inhibits the proliferation of human multiple myeloma cells by inducing apoptosis and G2/M cell cycle arrest: Involvement of Akt and p38 MAPK signalling pathway [PDF]

open access: yesActa Pharmaceutica
Deguelin exhibits antiproliferative activity against various cancer cell types. Previous studies have reported that deguelin exhibits pro-apoptotic activity against human cancer cells. The current study aimed at further elaborating the anticancer effects
Sun Kening   +4 more
doaj   +3 more sources

Intestinal deguelin drives resistance to acetaminophen-induced hepatotoxicity in female mice [PDF]

open access: yesGut Microbes
Acetaminophen (APAP) overdose is a leading cause of drug-induced liver injury (DILI), with gender-specific differences in susceptibility. However, the mechanism underlying this phenomenon remains unclear.
Shenhai Gong   +18 more
doaj   +2 more sources

Deguelin targets multiple oncogenic signaling pathways to combat human malignancies

open access: yesPharmacological Research, 2021
Cancer is an anomalous growth and differentiation of cells known to be governed by oncogenic factors. Plant-based natural metabolites have been well recognized to possess chemopreventive properties.
Aggarwal, Vaishali   +11 more
core   +3 more sources

The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts

open access: yesViruses, 2018
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus for which there is no vaccine or cure. This viral infection, once acquired, is life-long, residing latently in hematopoietic cells.
Eain A Murphy   +2 more
exaly   +3 more sources

Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.

open access: yesPLoS ONE, 2013
BackgroundTreatment of breast cancer patients with antiestrogens and aromatase inhibitor(s) or Herceptin have shown significant success in steroid receptor positive or Her-2+ breast cancers respectively.
Rajeshwari Mehta   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy